How to Tackle Early RA ?

Inflammation and disease activity in first year boost ACS risk. In patients with new-onset rheumatoid arthritis (RA) early disease control and other measures are essential to curb comorbid conditions that boost the risk of cardiovascular disease (CVD) and coronary events

Read more

Vitamin D May Improve Outcomes for Patients with Early RA

Standard treatment for rheumatoid arthritis (RA)—methotrexate and glucocorticoids—successfully improves clinical symptoms for most patients. Research by Ilaria Buondonno, PhD, and colleagues at the University of Torino, Italy, has revealed that the combination of a single dose of cholecalcipherol (300,000 IU) with standard treatment may go even further to improve the general health of patients with RA at three months relative to patients receiving standard therapy alone. The investigators published the results of their research, which evaluated patients at the very beginning of RA disease, online June 5 in PLoS One. Their intention was to investigate the early immunological alterations in patients with RA.

Read more